Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U10CA98543, HHSN261200800001E)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Target pediatric AML initiative
Received: 12 February 2022
Accepted: 9 November 2022
First Online: 23 November 2022
: The authors declare no competing interests.